Experts Available to Discuss Heart Health
ExpertSource:
TOPIC: February is National Heart Month and according to the American Heart Association, heart disease is the number one killer in the United States, according to an article appearing in The Daily Press. More than 61 million Americans are living with some form of cardiovascular disease. While risk factors such as age, gender and heredity can’t be reduced, through certain lifestyle changes, several risk factors can be controlled. For example, smoking, high blood cholesterol, stress, physical inactivity and high blood pressure can all increase the risk of heart disease and stroke.
EXPERTS: ExpertSource can offer several highly qualified experts to comment on this story:
Dr. Michael Yatcilla, R&D V.P. for Natrol, Inc., can discuss the importance of heart health awareness and affordable alternative supplements — such as Fish Oils, Omega Oils, and CoQ10 — for heart health protection. Dr. Yatcilla is an experienced physical scientist and engineer with a background in pharmaceuticals and biotechnology. Over the past decade, he has innovated new products for the nutraceutical industry. Dr. Yatcilla is published extensively in scientific and trade journals on nutraceutical science. He holds several nutraceutical patents. Prior to joining Natrol, Dr. Yatcilla held R&D positions at Cyvex Nutrition, Shaklee Corporation and, most recently, at Herbalife International (HLF) where he served as Director of Product Development. PR Contact: Stacy Taylor, 714.536.4635, stacytaylorpr@yahoo.com
Cindy Farricker is a registered and certified dietitian. Before coming to Dream Dinners, she worked as a consultant in Bellevue, Washington where she offered a variety of professional services including individualized nutrition therapy, consulting services and web based nutrition curriculum development. Additionally, she is affiliated with the University of Washington as a research dietitian and lecturer. Cindy has completed a Master of Science (MS) degree in clinical dietetics from University of Washington and obtained a Bachelor of Science degree in nutrition from Colorado State University. Additionally, she completed pediatric training at University of Washington Medical Center, The Center on Human Development and Disability at UW, and Children’s Hospital Medical Center in Seattle. She is also credentialed as a Certified Diabetes Educator (CDE). 206-601-3616, eatsmart@earthlink.net PR Contact: Nika Herford, 425-876-8987, nikah@dreamdinners.com
Former Lt. Cmdr., Ralph E. Holsworth, Jr., D.O. is a board-certified physician in Family Medicine who is internationally known through his research and publications in the area of enzyme enhanced medical treatment. Dr. Holsworth is a former commissioned officer in the U.S. Public Health Service. His premedical career started in the U.S. Navy as a nuclear power plant propulsion operator, serving on the USS Nimitz during the first Gulf War. He is also a media spokesperson, and an international guest speaker at medical conferences and conventions. Dr. Holsworth earned his BS degree in Geochemistry at the University of Texas in 1985 and his Doctorate of Osteopathy in 1997 from the College of Osteopathic Medicine in Kansas City, Missouri. He has been practicing as a family medicine physician with an emphasis on functional and integrative medicine since graduation. His specific interests are in cardiovascular health and systemic enzyme therapy where he has been involved in clinical and laboratory research for over a decade. Medical licensing is through the state of Colorado. He is an editorial board member at the Journal of Applied Clinical Thrombosis/Hemostasis and a member of the International Academy of Clinical and Applied Thrombosis/Hemostasis. PR Contact: Constance St. John, 415-454-2243, constjohn@aol.com
Richard B. Lanman, M.D., a leading expert on the early detection and treatment of heart disease and stroke, has an extensive background in advanced diagnostic blood and lipid testing. His expertise includes translating complex medical topics for nonclinical audiences. Lanman is executive vice president and chief medical officer for diaDexus, Inc., a privately held biotechnology company focused on the discovery, development, and commercialization of patent-protected diagnostic products with high clinical value. The company’s PLAC test is a simple blood test that measures levels of a new risk factor for coronary heart disease and stroke–lipoprotein-associated phospholipase A2 (Lp- PLA2). Lp-PLA2 is a cardiovascular-specific inflammatory marker implicated in the formation of vulnerable, rupture-prone plaque. Lanman most recently served as executive vice president, corporate development, and chief medical officer for Atherotech, Inc., an advanced cardiodiagnostic testing company. Prior to Atherotech, Lanman was founder, chairman, and chief executive officer of Adesso Healthcare Technology Services, an application service provider of quality and utilization profiling services for specialist physicians and health plans. Earlier in his career, he was senior vice president and medical director for San Jose Medical Group, and chief of quality at Kaiser Permanente in Northern California. Lanman is a highly sought after national speaker on the prevention and reversal of coronary heart disease, and has published several articles in medical journals. He earned his bachelor’s degree in chemistry at Stanford University and his medical degree at Northwestern University. PR Contact: Barbara Sullivan, 714-374-6174, bsullivan@sullivanpr.com
ExpertSource cannot guarantee the immediate availability of these experts or their familiarity with this specific issue.
ExpertSource provides academic and industry experts to the media at no charge. Journalists are encouraged to submit queries to ExpertSource when seeking experts on specific subjects. An online registration form is available at http://www.businesswire.com/.